# A Study of Cariprazine in Patients With Chronic Stable Schizophrenia

> **NCT00839852** · PHASE2 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 97 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Cariprazine

## Key facts

- **NCT ID:** NCT00839852
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05-31
- **Primary completion:** 2010-08-31
- **Final completion:** 2010-08-31
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2019-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00839852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00839852, "A Study of Cariprazine in Patients With Chronic Stable Schizophrenia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00839852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*